Growth Metrics

Emergent BioSolutions (EBS) Prepaid Assets (2016 - 2026)

Emergent BioSolutions has reported Prepaid Assets over the past 17 years, most recently at $26.9 million for Q1 2026.

  • For Q1 2026, Prepaid Assets fell 10.93% year-over-year to $26.9 million; the TTM value through Mar 2026 reached $26.9 million, down 10.93%, while the annual FY2025 figure was $25.8 million, 4.09% down from the prior year.
  • Prepaid Assets for Q1 2026 was $26.9 million at Emergent BioSolutions, up from $25.8 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $139.9 million in Q3 2022 and troughed at $24.0 million in Q2 2025.
  • A 5-year average of $52.6 million and a median of $41.7 million in 2023 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: soared 93.84% in 2022 and later tumbled 64.35% in 2023.
  • Year by year, Prepaid Assets stood at $57.9 million in 2022, then dropped by 17.27% to $47.9 million in 2023, then plummeted by 43.84% to $26.9 million in 2024, then decreased by 4.09% to $25.8 million in 2025, then grew by 4.26% to $26.9 million in 2026.
  • Business Quant data shows Prepaid Assets for EBS at $26.9 million in Q1 2026, $25.8 million in Q4 2025, and $25.6 million in Q3 2025.